Latest news
Improving oral care more than halves hospital-acquired pneumonia risk, major trial finds
A landmark trial presented at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia (NV-HAP) by 60%.
Researchers uncover a ‘treasure trove’ of bioactive molecules in coral reefs
Researchers have found that coral reefs are home to a vast array of previously unknown bioactive metabolites — small biomolecules that have the biotechnological potential to provide the basis for new drugs, and a host of other products.
Maternal RSV vaccination cuts infant hospitalization risk by over 80%, major study finds
The largest real-world study of its kind shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.
Turning microalgae into high-value fuels: biochar-based catalyst unlocks cleaner aromatic production
Scientists have designed a composite catalyst that significantly improves the quality of bio-oil derived from microalgae. By combining biochar with a well-known zeolite catalyst called HZSM-5, the team created a hybrid material that enhances the production of valuable aromatic hydrocarbons while minimizing unwanted byproducts.
HIV treatment reduces accelerated biological ageing by nearly four years, landmark study shows
A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ageing in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor HIV treatment and long-term health outcomes.
Graphitized biochar rewires soil microbes to accelerate pollutant breakdown in rice paddies
A new study reveals that a specially engineered form of biochar can dramatically enhance the natural ability of soil microbes to break down pollutants in rice paddies, offering a promising strategy for cleaner and more sustainable agriculture.
Improving oral care more than halves hospital-acquired pneumonia risk, major trial finds
A landmark trial presented at ESCMID Global 2026 shows that improving oral hygiene for hospital patients can reduce the risk of non-ventilator-associated hospital-acquired pneumonia (NV-HAP) by 60%.
Researchers uncover a ‘treasure trove’ of bioactive molecules in coral reefs
Researchers have found that coral reefs are home to a vast array of previously unknown bioactive metabolites — small biomolecules that have the biotechnological potential to provide the basis for new drugs, and a host of other products.
Maternal RSV vaccination cuts infant hospitalization risk by over 80%, major study finds
The largest real-world study of its kind shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks before birth.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
EnteroBiotix announces completion of enrolment in Phase 2a Trial evaluating EBX-102-02 prior to allogeneic stem cell transplantation
EnteroBiotix announced that the investigator-initiated Phase 2a MAST trial has completed its enrolment of 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) for defined haematological malignancies.
Color test ‘sniffs out’ dangerous staph strains fast
Researchers have developed a rapid colour-changing test that can distinguish between different strains of golden staph, including those likely to be virulent and antibiotic resistant.
Study reveals hidden damage in stony corals using 3D imaging and AI
Researchers investigating how disease affects coral structure turned to X-ray microcomputed tomography which generates detailed 3D reconstructions down to microscopic pores, which reveal internal skeletal features, including porosity, thickness and structural orientation, in a non-destructive way.
Nameko mucilage: An eco-friendly solution for microplastic pollution
Researchers use natural mucilage from nameko mushrooms for the removal of micro- and nano-plastics from water. The mucilage is rich in polysaccharides, particularly pectin—a naturally occurring plant-based compound—which is known for its particle-binding properties.
Three European countries reach 90% HPV vaccination target as Europe steps up action on cancer prevention
All EU/EEA countries now recommend HPV vaccination for adolescent girls and boys as part of their immunisation programmes, marking a major step forward in Europe’s’ cancer prevention efforts. Iceland, Portugal and Norway have reached the target of 90% HPV vaccination coverage among girls by the age of 15.
American microbiologist behind global water safety breakthrough wins 2026 Lee Kuan Yew Water Prize
Professor Joan Bray Rose has been recognised for pioneering Quantitative Microbial Risk Assessment (QMRA) as a global approach for assessing pathogen risks in water. QMRA has been adopted into global drinking water standards and enabled safe water reuse.
Molecular biologist Li-Jun Ma wins 2026 Mahoney Life Sciences Prize
Li-Jun Ma has been chosen as this year’s winner of the Mahoney Life Sciences Prize for her work toward mitigating the effects of a fungal pathogen that is causing the functional extinction of the bananas most commonly found in U.S. supermarkets.